Oncoprecision Raises $3.3M Seed Funding To Improve Cancer Patient Outcomes And Drug Development Efforts With “Patient Micro Avatars”
Amount Raised
$3.3 Million
Round Type
Seed
New YorkBiotechnologyHealth CareMedicalDescription
Today OncoPrecision announces $3.3 million in Seed Funding to further develop its Patient Micro Avatar technology which seeks to recreate cancer patients’ disease ex-vivo to precisely evaluate the response of these avatars to a wide range of both Standard of Care and explorational treatments within a week. The company’s goal is to unlock precise patient-specific insights that may help oncologists determine the best course of treatment, as well as to collaborate with the biopharmaceutical industry to optimize the development of transformational therapeutics.
Quick answer
OncoPrecision raised $3.3 Million in a Seed round, dated October 31, 2022. OncoPrecision is based in New York, United States.
- How much did OncoPrecision raise?
- OncoPrecision raised $3.3 Million in a Seed round on October 31, 2022.
- What does OncoPrecision do?
- We're developing technologies to replicate cancer patients' disease ex-vivo to rapidly and accurately test a broad range of treatments simultaneously to help oncologists provide the most suitable treatment for each..
- Where is OncoPrecision based and how big is it?
- OncoPrecision is based in New York, United States.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as OncoPrecision that raised within 45 days of this round, from Fundz verified event records.
- Fountain Life raised $15M on December 15, 2022.
- KeyOps raised $4M (Seed) on December 13, 2022.
- Ubie raised an undisclosed amount (Series C) on December 8, 2022.
- TRiCares raised $54M (Series C) on December 6, 2022.
- Nox Health raised an undisclosed amount (Corporate Round) on November 30, 2022.
- Medical Informatics raised $27M (Funding Round) on November 29, 2022.
Who to call at OncoPrecision, and when
A new round usually means OncoPrecision is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OncoPrecision raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OncoPrecision, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OncoPrecision. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OncoPrecision raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
OncoPrecision raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.